Ling Leung
2Patents
1h-index
11Co-inventors
34Inventor score
Filing activity: Jun 1, 2018 → Dec 7, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11225523B2 | Triple combination antibody therapies | Emerging Cross-Sectional Technologies | 1 | Active |
| US12152084B2 | Triple combination antibody therapies | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.